The role of good governance in the race for global vaccination during the COVID-19 pandemic.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
17 11 2021
17 11 2021
Historique:
received:
17
04
2021
accepted:
03
11
2021
entrez:
18
11
2021
pubmed:
19
11
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Governments have developed and implemented various policies and interventions to fight the COVID-19 pandemic. COVID-19 vaccines are now being produced and distributed globally. This study investigated the role of good governance and government effectiveness indicators in the acquisition and administration of COVID-19 vaccines at the population level. Data on six World Bank good governance indicators for 172 countries for 2019 and machine-learning methods (K-Means Method and Principal Component Analysis) were used to cluster countries based on these indicators and COVID-19 vaccination rates. XGBoost was used to classify countries based on their vaccination status and identify the relative contribution of each governance indicator to the vaccination rollout in each country. Countries with the highest COVID-19 vaccination rates (e.g., Israel, United Arab Emirates, United States) also have higher effective governance indicators. Regulatory Quality is the most important indicator in predicting COVID-19 vaccination status in a country, followed by Voice and Accountability, and Government Effectiveness. Our findings suggest that coordinated global efforts led by the World Health Organization and wealthier nations may be necessary to assist in the supply and distribution of vaccines to those countries that have less effective governance.
Identifiants
pubmed: 34789826
doi: 10.1038/s41598-021-01831-0
pii: 10.1038/s41598-021-01831-0
pmc: PMC8599507
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
22440Informations de copyright
© 2021. The Author(s).
Références
N Engl J Med. 2020 May 21;382(21):1969-1973
pubmed: 32227757
Sci Rep. 2020 Jul 24;10(1):12567
pubmed: 32709854
Science. 2021 Feb 19;371(6531):
pubmed: 33323424
Nat Med. 2020 Jul;26(7):1005-1008
pubmed: 32528155
J Med Virol. 2020 Jul;92(7):841-848
pubmed: 32243599
Science. 2020 May 29;368(6494):945-946
pubmed: 32385100
JAMA. 2020 Aug 4;324(5):439-440
pubmed: 32749496